News Events Publications
News
News-Archive
Study site in 4 more countries open for recruitment
published: September 5th 2019
During the first half of 2019, study sites in Finland, Norway, Belgium and Italy have opened for patient recruitment. In total, ALBINO is now recruiting in 10 countries.
Recruitment now open in Estonia and Spain
published: March 14th 2019
The ALBINO-consortium happily announces the official opening of the first centers for patient recruitment in Estonia and Spain.
Recruitment open and first patient included in Austria
published: November 28th 2018
Recruitment for the ALBINO-study was successfully opened in Austria, and the first patient has been enrolled already.
First Patients Included
published: July 10th 2018
Since the opening of the first study sites in the Netherlands and Germany, 4 patients have been successfully included into the ALBINO-trial (2 in the Netherlands, 2 in Germany).
Recruitment now open in Switzerland
published: July 10th 2018
The ALBINO-consortium happily announces the official opening of two centres for patient recruitment in Switzerland.Recruitment now open in the Netherlands and Germany
published: June 6th 2018
The ALBINO-consortium happily announces the official opening of several centres for patient recruitment in the Netherlands and Germany. We are confident that more countries will follow soon.
Approvals received in Portugal
published: November 21st 2019
On 08 November, 2019 partner UPORTO received all necessary approvals to start patient recruitment for the ALBINO-trial in Portugal. Portugal is now the 11th country recruiting for ALBINO.
Events
Past Events
ALBINO Investigator Meeting at GNPI 2020, June 18th 2020
The ALBINO-trial will be present at the 46th Annual Conference of the German Society for Neonatology and Paediatric Intensive Care (GNPI) in Berlin, Germany, Estrel-Hotel and Congress Center, from June 18-20, 2020.
Further information is available at gnpi2020.de.
ALBINO-investigators from Germany, Austria and Switzerland will convene room NIZZA on Friday, 18 June, 2020, 11.15-12.15 am. All participating investigators and interested new investigators are cordially invited to join and learn about the latest news and conditions for trial participation.
ALBINO Presentation at the 11th Dresden Symposium on Delivery Room Management and Regenerative Therapies, March 5th 2020
The ALBINO-trial will be presented by Axel Franz in the session on Neonatal Brain Injury on Thursday, 05 March, 2020.
Further information is available at here
Next ALBINO General Assembly Meeting in Berlin, March 4th 2020
The members of the ALBINO-consortium will once again meet on 04 March, 2020 at Berlin, Tegel Airport.
ALBINO Investigator Meeting in Germany, May 24th 2019
The next investigator meeting for participating and interested centers will take place at the annual GNPI congress 2019 in Leipzig. The meeting will be held on 24 May, 2019, 12-1pm.
ALBINO Consortium Meeting in Germany, April 10th 2019
The ALBINO consortium will convene in Frankfurt, Germany on 10 April, 2019 for its first consortium meeting in 2019.
ALBINO Investigator Meetings in Italy and Norway, June 11th 2018
In order to speed up the trial roll-out in further European countries, investigator meetings will be held in Italy and Norway. In Italy the meeting will take place at the Hotel Courtyard by Marriott in Tessera, Venice on 11 June, 2018, 11 am to 4 pm. In Norway, investigators will convene at Oslo University Hospital on 12 June, 2018, from 9 am until 4 pm.
ALBINO Investigator Meeting at GNPI 2018, June 9th 2018
The ALBINO-trial will be present at the 44th Annual Conference of the German Society for Neonatology and Paediatric Intensive Care (GNPI) in Rostock, Germany, from June 07-09, 2018. Further information is available at www.gnpi2018.de.
ALBINO-investigators from Germany, Austria and Switzerland will convene in Hall 8 on Saturday, 09 June, 2018, 12.45-1.45 pm. All participating investigators and interested new investigators are cordially invited to join and learn about the latest news and conditions for trial participation.
ALBINO presented at the “9th Dresden Symposium on Delivery Room Manage-ment, Asphyxia, Hypothermia and Stem cell research, March 9th 2018
The progress and state of affairs of the ALBINO-study will be presented at the “9th Dresden Symposium on Delivery Room Management, Asphyxia, Hypothermia and Stem cell re-search” which is held from 08-09 March, 2018 in Dresden, Germany. This symposium is a regular convention of national and international researchers and experts on hypothermia, and we hope for interesting inputs and discussions for various perspectives.
Annual ALBINO-Meeting to be held in Dresden, Germany, March 7th 2018
The ALBINO-consortium will hold its annual meeting in Dresden, Germany on 07 March, 2018. For the 2nd time, the annual spring meeting will be hosted by TUD and EKUT. We are looking forward to fruitful discussions among all partners.
Publication
Second peer-reviewed publication on ALBINO now available in BMC Pediatrics
Maiwald et al.’s paper “Effect of allopurinol in addition to hypothermia treatment in neonates for hypoxic-ischemic brain injury on neurocognitive outcome (ALBINO): study protocol of a blinded randomized placebo controlled parallel group multicenter trial for superiority (phase III)” is now available in BMC Pediatrics. Please visit https://rdcu.be/bH0i2 for open access to full text.
First peer-reviewed journal article on ALBINO has been published
Annink et al.’s review article “Allopurinol: Old Drug, New Indication in Neonates?“ is now available in Current Pharmaceutical Design, https://benthamscience.com/journals/current-pharmaceutical-design.